Literature DB >> 22709516

Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Henrick Schomacker1, Anne Schaap-Nutt, Peter L Collins, Alexander C Schmidt.   

Abstract

Human parainfluenza viruses (HPIVs) are a common cause of acute respiratory illness throughout life. Infants, children, and the immunocompromised are the most likely to develop severe disease. HPIV1 and HPIV2 are best known to cause croup while HPIV3 is a common cause of bronchiolitis and pneumonia. HPIVs replicate productively in respiratory epithelial cells and do not spread systemically unless the host is severely immunocompromised. Molecular studies have delineated how HPIVs evade and block cellular innate immune responses to permit efficient replication, local spread, and host-to-host transmission. Studies using ex vivo human airway epithelium have focused on virus tropism, cellular pathology and the epithelial inflammatory response, elucidating how events early in infection shape the adaptive immune response and disease outcome. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22709516      PMCID: PMC3514439          DOI: 10.1016/j.coviro.2012.02.001

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  79 in total

1.  Giant-cell pneumonia caused by parainfluenza virus.

Authors:  G Delage; P Brochu; M Pelletier; G Jasmin; N Lapointe
Journal:  J Pediatr       Date:  1979-03       Impact factor: 4.406

Review 2.  Interferon signalling network in innate defence.

Authors:  Akinori Takaoka; Hideyuki Yanai
Journal:  Cell Microbiol       Date:  2006-06       Impact factor: 3.715

3.  Identification of human parainfluenza virus type 2 (HPIV-2) V protein amino acid residues that reduce binding of V to MDA5 and attenuate HPIV-2 replication in nonhuman primates.

Authors:  Anne Schaap-Nutt; Caraline Higgins; Emerito Amaro-Carambot; Sheila M Nolan; Christopher D'Angelo; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon-beta.

Authors:  Emma Poole; Biao He; Robert A Lamb; Richard E Randall; Stephen Goodbourn
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

5.  The relationship between respiratory viral loads and diagnosis in children presenting to a pediatric hospital emergency department.

Authors:  Soraya Utokaparch; David Marchant; John V Gosselink; John E McDonough; Eva E Thomas; James C Hogg; Richard G Hegele
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

6.  Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.

Authors:  Laura M Palermo; Matteo Porotto; Christine C Yokoyama; Samantha G Palmer; Bruce A Mungall; Olga Greengard; Stefan Niewiesk; Anne Moscona
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

7.  Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.

Authors:  Emmalene J Bartlett; Margaret Hennessey; Mario H Skiadopoulos; Alexander C Schmidt; Peter L Collins; Brian R Murphy; Raymond J Pickles
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

8.  Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.

Authors:  Emmalene J Bartlett; Ann-Marie Cruz; Janice Esker; Adam Castaño; Henrick Schomacker; Sonja R Surman; Margaret Hennessey; Jim Boonyaratanakornkit; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  J Virol       Date:  2008-07-09       Impact factor: 5.103

9.  The parainfluenza virus type 1 P/C gene uses a very efficient GUG codon to start its C' protein.

Authors:  R Boeck; J Curran; Y Matsuoka; R Compans; D Kolakofsky
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

10.  Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children.

Authors:  Ruth A Karron; Bhagvanji Thumar; Elizabeth Schappell; Sonja Surman; Brian R Murphy; Peter L Collins; Alexander C Schmidt
Journal:  Vaccine       Date:  2011-12-14       Impact factor: 3.641

View more
  36 in total

1.  Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study.

Authors:  Crystal W Burke; Mei Li; Julia L Hurwitz; Peter Vogel; Charles J Russell
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

Review 2.  Receptor-mediated cell entry of paramyxoviruses: Mechanisms, and consequences for tropism and pathogenesis.

Authors:  Chanakha K Navaratnarajah; Alex R Generous; Iris Yousaf; Roberto Cattaneo
Journal:  J Biol Chem       Date:  2020-01-16       Impact factor: 5.157

Review 3.  T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders.

Authors:  Anne Monette; Andrew J Mouland
Journal:  Int Rev Cell Mol Biol       Date:  2018-10-24       Impact factor: 6.813

4.  Characterization of a key residue for hyperfusogenic phenotype in human parainfluenza virus type 2 (hPIV-2) fusion glycoprotein.

Authors:  Jean-Christophe Le Bayon; Olivier Terrier; Gaëlle Cartet; Bruno Lina; Manuel Rosa-Calatrava
Journal:  Virus Genes       Date:  2013-06-08       Impact factor: 2.332

5.  Coinfection of Swiss cattle with bovine parainfluenza virus 3 and Mycoplasma bovis at acute and chronic stages of bovine respiratory disease complex.

Authors:  Kemal Mehinagic; Paola Pilo; Beatriz Vidondo; Nadine Stokar-Regenscheit
Journal:  J Vet Diagn Invest       Date:  2019-06-27       Impact factor: 1.279

6.  Epicatechin analogues may hinder human parainfluenza virus infection by inhibition of hemagglutinin neuraminidase protein and prevention of cellular entry.

Authors:  Sidharth Bhasin; Megh Nadar; Yasha Hasija
Journal:  J Mol Model       Date:  2022-09-16       Impact factor: 2.172

7.  Severe parainfluenza pneumonia in a case of transient hypogammalobulinemia of infancy.

Authors:  Nicola Cotugno; Emma Concetta Manno; Francesca Stoppa; Serena Sinibaldi; Claudia Saffirio; Parizia D'Argenio; Marco Marano; Matteo Di Nardo; Paolo Palma
Journal:  BMJ Case Rep       Date:  2013-06-26

Review 8.  The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell-derived lung progenitors in 3D.

Authors:  Ana Luisa Rodrigues Toste de Carvalho; Hsiao-Yun Liu; Ya-Wen Chen; Matteo Porotto; Anne Moscona; Hans-Willem Snoeck
Journal:  Nat Protoc       Date:  2021-03-01       Impact factor: 17.021

Review 9.  Evolutionary history of cotranscriptional editing in the paramyxoviral phosphoprotein gene.

Authors:  Jordan Douglas; Alexei J Drummond; Richard L Kingston
Journal:  Virus Evol       Date:  2021-03-27

Review 10.  Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.

Authors:  Yinghan Chan; Sin Wi Ng; Sachin Kumar Singh; Monica Gulati; Gaurav Gupta; Sushil Kumar Chaudhary; Goh Bey Hing; Trudi Collet; Ronan MacLoughlin; Raimar Löbenberg; Brian G Oliver; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Life Sci       Date:  2021-06-24       Impact factor: 6.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.